Andrew Jeremijenko

6.3k total citations
19 papers, 366 citations indexed

About

Andrew Jeremijenko is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Andrew Jeremijenko has authored 19 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Modeling and Simulation and 5 papers in Epidemiology. Recurrent topics in Andrew Jeremijenko's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 epidemiological studies (7 papers) and COVID-19 Clinical Research Studies (3 papers). Andrew Jeremijenko is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 epidemiological studies (7 papers) and COVID-19 Clinical Research Studies (3 papers). Andrew Jeremijenko collaborates with scholars based in Qatar, United States and Australia. Andrew Jeremijenko's co-authors include Adeel A. Butt, Abdul‐Badi Abou‐Samra, Moza Alishaq, Robyn Attewell, B. Sibthorpe, Hanna Kelly, Peter Coyle, Laith J. Abu‐Raddad, Yasmin A. Mohamoud and Jayaprakash Saththasivam and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Andrew Jeremijenko

19 papers receiving 355 citations

Peers

Andrew Jeremijenko

HEALT

Yu‐Lin Tai Taiwan

Sharon Hui Xuan Tan Singapore

Seungjae Lee South Korea

Hakjun Hyun South Korea

Amoolya Vusirikala United Kingdom

Frank Naujoks Germany

Karl Soetebier United States

Jason Rippe United States

So Yun Lim South Korea

Mande Toubkin South Africa

Yu‐Lin Tai Taiwan

Andrew Jeremijenko

209 ×0.8

73 ×0.8

76 ×1.3

HEALT

73 ×1.4

16 ×0.4

Citations per year, relative to Andrew Jeremijenko Andrew Jeremijenko (= 1×) peers Yu‐Lin Tai

Countries citing papers authored by Andrew Jeremijenko

Since Specialization

Citations

This map shows the geographic impact of Andrew Jeremijenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Jeremijenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Jeremijenko more than expected).

Fields of papers citing papers by Andrew Jeremijenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Jeremijenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Jeremijenko. The network helps show where Andrew Jeremijenko may publish in the future.

Co-authorship network of co-authors of Andrew Jeremijenko

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Jeremijenko. A scholar is included among the top collaborators of Andrew Jeremijenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Jeremijenko. Andrew Jeremijenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Rajan, Ronnie, et al.. (2025). Population-scale cross-sectional observational study for AI-powered TB screening on one million CXRs. npj Digital Medicine. 8(1). 418–418. 1 indexed citations

Muraki, Katsuhiko, Natalie Eaton-Fitch, Peter Smith, et al.. (2024). Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target. Frontiers in Immunology. 15. 1264702–1264702. 2 indexed citations

Smoll, Nicolas R., et al.. (2022). Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectiveness. Communicable Diseases Intelligence. 46. 1 indexed citations

Ayoub, Houssein H., Hiam Chemaitelly, Monia Makhoul, et al.. (2021). Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses. BMJ Innovations. 7(2). 327–336. 17 indexed citations

Schumacher, Yorck Olaf, Montassar Tabben, Karim Chamari, et al.. (2021). Environmental surface contamination with SARS-CoV-2 in professional football clubs. Science and Medicine in Football. 5(sup1). 8–12. 3 indexed citations

Alishaq, Moza, et al.. (2021). Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system. PLoS ONE. 16(9). e0257845–e0257845. 8 indexed citations

Alishaq, Moza, Andrew Jeremijenko, Hanaa Nafady‐Hego, et al.. (2021). SARS-CoV-2 infection in mortuary and cemetery workers. International Journal of Infectious Diseases. 105. 621–625. 8 indexed citations

Saththasivam, Jayaprakash, Tricia Gomez, Khadeeja Abdul Jabbar, et al.. (2021). COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar. The Science of The Total Environment. 774. 145608–145608. 87 indexed citations

Alishaq, Moza, Andrew Jeremijenko, Hanaa Nafady‐Hego, et al.. (2021). SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term. BMC Public Health. 21(1). 2070–2070. 2 indexed citations

10.

Alishaq, Moza, Hanaa Nafady‐Hego, Andrew Jeremijenko, et al.. (2021). Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers. PLoS ONE. 16(10). e0258820–e0258820. 33 indexed citations

11.

Seedat, Shaheen, Hiam Chemaitelly, Houssein H. Ayoub, et al.. (2021). SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar. Scientific Reports. 11(1). 18182–18182. 13 indexed citations

12.

Ayoub, Houssein H., Hiam Chemaitelly, Shaheen Seedat, et al.. (2021). Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19. Journal of Global Health. 11. 5005–5005. 17 indexed citations

13.

Omrani, Ali S., Sameer A. Pathan, Sarah A. Thomas, et al.. (2020). Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19. EClinicalMedicine. 29-30. 100645–100645. 36 indexed citations

14.

Jeremijenko, Andrew, et al.. (2020). COVID-19 infection among healthcare workers in a national healthcare system: The Qatar experience. International Journal of Infectious Diseases. 100. 386–389. 75 indexed citations

15.

Jeremijenko, Andrew, Mary‐Louise McLaws, & Herman Kosasih. (2007). A Tsunami Related Tetanus Epidemic in Aceh, Indonesia. Asia Pacific Journal of Public Health. 19(1_suppl). 40–44. 13 indexed citations

16.

Cox, Robert W., et al.. (2007). Expatriate Health and Welfare: The Hidden Costs of Getting It Wrong. 4 indexed citations

17.

Cox, Robert W., et al.. (2007). Expatriate Health and Welfare: The Hidden Costs of Getting It Wrong. 4 indexed citations

18.

Jeremijenko, Andrew, Hanna Kelly, B. Sibthorpe, & Robyn Attewell. (1996). Improving vaccine storage in general practice refrigerators: Table 1. BMJ. 312(7047). 1651–1652. 34 indexed citations

19.

Jeremijenko, Andrew, H. William Kelly, & Mahomed Patel. (1996). The high morbidity associated with a measles outbreak in a West Australian town. Journal of Paediatrics and Child Health. 32(5). 382–385. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact